ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,408.98
-0.76%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Syncona Limited (SYNC)

  7. Syncona Limited (SYNC) Noticias

SYNC

Syncona (SYNC)

Syncona Limited
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:SYNC
FechaHoraFuenteTítuloSímboloCompañía
03/05/202401:00RNS Regulatory NewsSyncona Limited Transaction in Own SharesLSE:SYNCSyncona Limited
01/05/202408:14RNS Regulatory NewsSyncona Limited Total Voting RightsLSE:SYNCSyncona Limited
11/04/202408:22Alliance NewsAlliance NewsSyncona agrees to sell stake in investee company for GBP7.4 millionLSE:SYNCSyncona Limited
11/04/202406:02RNS Regulatory NewsSyncona Limited Century Therapeutics to acquire Clade TherapeuticsLSE:SYNCSyncona Limited
04/04/202411:06Alliance NewsAlliance NewsIN BRIEF: Syncona notes investee Achilles's annual loss narrowsLSE:SYNCSyncona Limited
04/04/202405:50RNS Regulatory NewsSyncona Limited Achilles reports full year 2023 Financial ResultsLSE:SYNCSyncona Limited
04/04/202405:47RNS Regulatory NewsSyncona Limited Achilles provides clinical data updateLSE:SYNCSyncona Limited
14/03/202409:16Alliance NewsAlliance NewsSyncona portfolio company Autolus posts widened loss for 2023LSE:SYNCSyncona Limited
14/03/202406:05RNS Regulatory NewsSyncona Limited Autolus reports full year 2023 Financial ResultsLSE:SYNCSyncona Limited
06/03/202411:22RNS Regulatory NewsSyncona Limited Director DeclarationLSE:SYNCSyncona Limited
20/02/202406:02RNS Regulatory NewsSyncona Limited Acquisition of Freeline Becomes EffectiveLSE:SYNCSyncona Limited
12/02/202412:01Alliance NewsAlliance NewsIN BRIEF: Freeline shareholders approve Syncona acquisitionLSE:SYNCSyncona Limited
12/02/202410:45RNS Regulatory NewsSyncona Limited Freeline Shareholders Approve AcquisitionLSE:SYNCSyncona Limited
08/02/202407:45Alliance NewsAlliance NewsUPDATE: Syncona portfolio strengthens thanks to AutolusLSE:SYNCSyncona Limited
08/02/202406:53RNS Regulatory NewsSyncona Limited Autolus offering (Amendment)LSE:SYNCSyncona Limited
08/02/202406:13RNS Regulatory NewsSyncona Limited Autolus announces pricing of public offeringLSE:SYNCSyncona Limited
08/02/202406:05RNS Regulatory NewsSyncona Limited Beacon presents 12-month clinical dataLSE:SYNCSyncona Limited
08/02/202404:50RNS Regulatory NewsSyncona Limited Autolus announces Strategic CollaborationLSE:SYNCSyncona Limited
08/02/202403:41Alliance NewsAlliance NewsSyncona portfolio strengthens in third quarter thanks to AutolusLSE:SYNCSyncona Limited
08/02/202401:00RNS Regulatory NewsSyncona Limited Third Quarter UpdateLSE:SYNCSyncona Limited
22/01/202406:19Alliance NewsAlliance NewsIN BRIEF: Syncona notes FDA acceptance of Autolus's BLA for obe-celLSE:SYNCSyncona Limited
22/01/202406:05UK RegulatorySyncona Limited Autolus announces acceptance of BLA for obe-celLSE:SYNCSyncona Limited
19/01/202402:36Alliance NewsAlliance NewsSyncona says Freeline trial for Gaucher disease treatment positiveLSE:SYNCSyncona Limited
19/01/202401:00UK RegulatorySyncona Limited Freeline announces further dataLSE:SYNCSyncona Limited
11/12/202301:00UK RegulatorySyncona Limited Autolus presents clinical data updatesLSE:SYNCSyncona Limited
04/12/202303:37Alliance NewsAlliance NewsIN BRIEF: Syncona notes Beacon's "encouraging" AGTC-501 trial dataLSE:SYNCSyncona Limited
04/12/202301:00UK RegulatorySyncona Limited Beacon presents data from AGTC-501 in XLRPLSE:SYNCSyncona Limited
27/11/202313:03Alliance NewsAlliance NewsTRADING UPDATES: Molten Ventures completes raise; Saietta proposes oneLSE:SYNCSyncona Limited
27/11/202306:05UK RegulatorySyncona Limited Autolus submits key regulatory filing for obe-celLSE:SYNCSyncona Limited
22/11/202308:30Alliance NewsAlliance NewsIN BRIEF: Syncona agrees to buyout deal with Freeline TherapeuticsLSE:SYNCSyncona Limited
 Showing the most relevant articles for your search:LSE:SYNC

Su Consulta Reciente

SPI
SP500
S&P 500
NASDAQ
AAPL
Apple
AMEX
XLF
Financial Select Sector
USOTC
ADDYY
Adidas (QX)
NASDAQ
GOOGL
Alphabet
NYSE
KO
Coca Cola
USOTC
RHHBY
Roche (QX)
NASDAQ
MSFT
Microsoft
COIN
BTCUSD
Bitcoin
FX
EURUSD
Euro vs US Dollar
CCOM
US30
US 30
USOTC
BNPQY
BNP Paribas (QX)
NYSE
VZ
Verizon Communications
NASDAQ
NVDA
NVIDIA
FX
EURMXN
Euro vs MXN
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados